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Influenza A virus (IAV) is among the most common causes of pneumonia related death worldwide. Pulmonary 
epithelial cells are the primary target for viral infection and replication and respond by releasing inflammatory 
mediators that recruit immune cells to mount the host response. Severe lung injury and death during IAV 
infection results from an exuberant host inflammatory response. The linear ubiquitin assembly complex 
(LUBAC), composed of SHARPIN, HOIL-1L and HOIP, is a critical regulator of NF-κB-dependent inflammation. 
Using mice with lung epithelial specific deletions of HOIL-1L or HOIP in a model of IAV infection, we provided 
evidence that, while a reduction in the inflammatory response was beneficial, ablation of the LUBAC-
dependent lung epithelial-driven response worsened lung injury and increased mortality. Moreover, we 
described a mechanism for the upregulation of HOIL-1L in infected and non-infected cells triggered by the 
activation of type I interferon receptor and mediated by IRF1, which was maladaptive and contributed to hyper-
inflammation. Thus, we propose that lung epithelial LUBAC acts as a molecular rheostat that could be 









Seasonal influenza A viral infection affects a significant proportion of the population in the United States and 
worldwide. While most patients infected with influenza A virus (IAV) recover without major sequelae, severe 
viral pneumonia is one of the most common causes of acute respiratory distress syndrome (ARDS) (1-4) . 
Impairment of gas exchange in IAV-induced ARDS, in large part, is due to damage to the alveolar epithelial 
barrier and edema accumulation (1, 4-6). During IAV infection an exaggerated inflammatory response, known 
as “cytokine storm”, can occur which disrupts the alveolar epithelial barrier and leads to the development of 
ARDS (5), increasing IAV-induced morbidity and mortality. 
Alveolar epithelial cells (AEC) are targets of IAV infection and orchestrate the host immune response 
necessary for viral clearance (7, 8). As IAV replicates within AEC, viral particles accumulate in the cytosol and 
are sensed by the host pattern recognition receptor retinoic acid-inducible gene I (RIG-I), inducing the 
production of cytokines and interferons (9-11). AEC-derived cytokines and interferons promote recruitment of 
host immune cells which release additional cytokines and proteases in an effort to limit viral spread (5). 
However, the non-specific nature of the innate immune response can damage non-infected adjacent cells (5, 
7). As AEC die, either by direct infection or as a consequence of the inflammatory response, the alveolar 
barrier becomes permeable to solutes leading to edema accumulation and impaired gas exchange (5, 7, 12). 
Data from animal models of severe IAV infection suggest that “cytokine storm” is the major driver of morbidity 
and mortality (13-17). Several studies suggest that reductions in circulating cytokines improve lung injury and 
survival, highlighting the importance of modulating the host inflammatory response during IAV infection (14, 18, 
19).   
The linear ubiquitin assembly complex (LUBAC) is essential for NF-κB activation, where it targets the NF-κB 
essential modulator (NEMO) for linear ubiquitination (20-24). LUBAC is an E3-ligase complex composed of the 
accessory protein, Shank-Associated RH domain-Interacting Protein (SHARPIN), as well as two RING-in-
between-RING ligases: the Heme-Oxidized Iron responsive element binding protein 2 ubiquitin Ligase-1L 
(HOIL-1L) and the catalytically active component HOIL-1-Interacting Protein (HOIP) (20, 25, 26). Unlike most 
ubiquitin E3 ligases, which utilize the internal lysine residues of ubiquitin, LUBAC forms Met-1-linked head-to-
tail linear ubiquitin chains (20, 22, 25). While the exact stoichiometry of the 600 kDa complex has yet to be 
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elucidated, the presence of all three LUBAC components is necessary for its stability and maximal activity, 
despite HOIP being the only catalytically active component of the complex (25, 27). Predominantly studied 
downstream of TNF receptor superfamily (TNFRSF), linear ubiquitin chains on NEMO stabilize the IκB kinase 
(IKK) complex, consisting of NEMO, IKKα and IKKβ, enabling the phosphorylation and degradation IκBα, 
releasing NF-κB to translocate to the nucleus, stimulating downstream inflammation (21, 28, 29). NEMO can 
also form a complex that can activates interferon regulatory factor 3 (IRF3), initiating its dimerization and 
translocation to the nucleus, where it drives type I interferon production to modulate the antiviral response (30). 
While the role of LUBAC in NF-κB signaling downstream of TNFRSF has been well established, the role of 
alveolar epithelial LUBAC in regulating NF-κB-dependent inflammation downstream of RIG-I during IAV 
infection is unknown.  
In this study, we report that the degree of LUBAC activity determines the alveolar epithelial-driven inflammatory 
response to IAV infection. During IAV infection, type I interferon upregulates HOIL-1L expression in AEC and 
thus enhances LUBAC formation, leading to an exaggerated inflammatory response and severe lung injury. In 
agreement with a role of alveolar epithelial LUBAC driving the lung inflammatory response, reducing the 
complex formation by using a transgenic mice with a lung epithelial cell-specific deletion of HOIL-1L protected 
mice from severe lung injury and increased survival. Moreover, complete loss of lung epithelial LUBAC activity, 
as observed in mice with a genetic deletion of HOIP from the lung epithelium, worsened outcomes during IAV 
infection. As such, this work uncovers a novel role for LUBAC as a rheostat of the epithelial-driven 
inflammatory response to IAV infection, which could be targeted as a potential therapeutic strategy for control 





Linear ubiquitin chains regulate the NF-κB response to IAV downstream of RIG-I signaling 
We infected an alveolar epithelial cell line (A549) with H1N1 A/WSN/1933 (WSN) at 1 MOI, for 16 hours, a 
dose and time at which we observed RIG-I-dependent NF-κB and IRF3 activation (measured by the 
phosphorylation relative to total IκBα and IRF3 respectively), NEMO ubiquitination, and cytokine production 
(Figure 1, Supplemental Figure 1A-C). After siRNA silencing of either HOIL-1L or HOIP, we detected no 
appreciable differences in RIG-I activation as compared to control siRNA treated cells in response to WSN 
infection (Figure 1B-C, Supplemental Figure 1D-E). However, analysis of NEMO-ubiquitination after 
immunoprecipitation from cell lysates showed that loss of LUBAC components resulted in a graded decrease 
of linear chains, were silenced HOIL-1L reduced their abundance and siHOIP inhibited the linear ubiquitin of 
NEMO during IAV infection (Figure 1D). Downstream of NEMO linear ubiquitination, silencing of HOIL-1L or 
HOIP decreased in the IAV-induced activation of NF-κB and IRF3 as well as the secretion of IL-6 and IFN-β in 
a similarly graded manner (Figure 1E-G, Supplemental Figure 1F-G). Together these results suggest that 
LUBAC regulates the inflammatory and antiviral response downstream of RIG-I signaling in response to IAV.   
Loss of HOIL-1L from the lung epithelium reduces lung injury and improves survival in mice infected 
with IAV 
To evaluate whether LUBAC activity in the lung epithelium regulates IAV induced lung injury, we generated 
mice with a tissue specific deletion of full length HOIL-1L (SPCcre/HOIL-1Lfl/fl) (31).  These mice were generated 
using the same construct described for the well defined HOIL-1L-/- mice (21, 31), which do not express full 
length HOIL-1L, but instead express a 30kDa  truncated variant (21) that results in reduced levels of 600 kDa 
LUBAC (32) as well as impaired NF-κB signaling (21). Immunoblots of mouse alveolar type 2 (AT2) cells 
lysates using either a specific antibody against the C- terminus (21, 31) or N-terminus of HOIL-1L (33), showed 
a band at approximately 55 kDa in WT AT2 cells, corresponding to the molecular weight of full-length HOIL-1L, 
that was absent in SPCcre/HOIL-1Lfl/fl AT2 cell lysates (Supplemental Figure 2A-b). Additionally, using the 
HOIL-1L N-terminus antisbody we observed a low abundance band at approximately 30 kDa in SPCcre/HOIL-
1Lfl/fl AT2 cells (Supplemental Figure 2A) (33). This observation is in agreement with the description of the 30 
kDa band in lysates from HOIL-1L-/- mice which represents a truncated splice variant of HOIL-1L lacking the C-
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terminal RING domain but retaining its ubiquitin-like (UBL) domain for interaction with HOIP as well as its 
LUBAC-tethering motif (LTM) necessary for interactions with SHARPIN (21, 33, 34). The absence of HOIL-1L 
can destabilize the complex and decrease HOIP and SHARPIN expression (27, 33, 35), however, we observe 
no significant change in HOIP expression between WT and SPCcre/HOIL-1Lfl/fl AT2 cells (Supplemental Figure 
2B). Interestingly, we observed a slight increase in SHARPIN expression in SPCcre/HOIL-1Lfl/fl AT2 cells 
compared to WT (Supplemental Figure 2B). SHARPIN is sufficient to stabilize HOIP and promote LUBAC 
activity in the absence of HOIL-1L , albeit with lower efficiency compared with complexes containing HOIL-1L 
(27), supporting the notion that respiratory epithelial cells in SPCcre/HOIL-1Lfl/fl mice retain some degree of 
LUBAC activity.  
WT and SPCcre/HOIL-1Lfl/fl mice were infected intratracheally (i.t.) with a low or lethal dose of WSN and 
monitored for survival. Low dose WSN infection resulted in ~75% survival of SPCcre/HOIL-1Lfl/fl mice compared 
to 40% in WT mice at 20 days post infection (d.p.i.) (Figure 2A). A lethal dose of WSN, resulted in 100% 
mortality of WT mice by 12 d.p.i., while ~20% SPCcre/HOIL-1Lfl/fl mice survived. The differences in mortality 
during infection with WSN corresponded with decreased severity of lung injury in SPCcre/HOIL-1Lfl/fl mice, 
assessed by measuring total protein content in bronchoalveolar lavage fluid (BALF), which was decreased by 
~25% at 5 d.p.i. and ~20% at 7 d.p.i. with the lethal dose as compared to WT mice (Figure 2B). In agreement 
with reduced barrier permeability, at the same time points we detected a significant decrease in total cell count 
in BALF in SPCcre/HOIL-1Lfl/fl mice as compared to WT mice (Figure 2C). Careful examination of multiple 
parameters in H&E stained lung sections, including peribronchial infiltration, bronchial exudate, alveolar 
infiltration, and thickening of alveolar walls showed reduced severity of lung injury in SPCcre/HOIL-1Lfl/fl mice as 
compared to WT at 7 d.p.i. with low dose WSN (Supplemental Figure 2C-D). Moreover, in WT mice we 
observed that a lethal dose of WSN resulted in peak viremia at 5 d.p.i. which was decreased by 27% in 
SPCcre/HOIL-1Lfl/fl mice with no significant differences in clearance at 7 d.p.i. (Figure 2D). 
BALF samples from WT and SPCcre/HOIL-1Lfl/fl mice were further analyzed to determine cytokine content after 
lethal WSN infection. WT mice infected with WSN had high levels of IL-6 (Figure 3A), MCP-1, and IFN-γ by 5 
d.p.i. that remained elevated through 7 d.p.i., all of which were significantly reduced in the BALF of WSN 
infected SPCcre/HOIL-1Lfl/fl mice (Supplemental Figure 2E-F), while BALF levels of TNF-αwere similarly 
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elevated in both strains (Supplemental Figure 2G). Additionally, at 3 and 5 d.p.i. type I interferons (IFN-α, IFN-
β) were significantly reduced in SPCcre/HOIL-1Lfl/fl compared to WT mice (Figure 3B-C). Conversely, at 7 d.p.i. 
BALF from SPCcre/HOIL-1Lfl/fl mice contained 2-fold higher levels of the anti-inflammatory cytokine IL-10 
(Supplemental Figure 2H). At 5 d.p.i. we also observed reduced levels of IL-1β in the BALF of SPCcre/HOIL-
1Lfl/fl mice compared to WT mice (Supplemental Figure 2I) that corresponded with reduced Il1b transcription in 
isolated SPCcre/HOIL-1Lfl/fl AT2  (Supplemental Figure 2J) with no defect in SPCcre/HOIL-1Lfl/fl AT2 
inflammasome activation compared to WT AT2 at 5 d.p.i (Supplemental Figure 2K). Taken together these 
results suggest that loss of full length HOIL-1L from lung epithelial cells confers protection during IAV infection 
by altering the ratio of pro-inflammatory and anti-inflammatory cytokines and reducing the levels of interferons.  
AEC-derived cytokines and interferons promote recruitment and activation of immune cells (5). To determine 
the effect of loss of HOIL-1L on the innate immune response, we analyzed lung myeloid and lymphoid 
populations in WT and SPCcre/HOIL-1Lfl/fl lungs at 0, 3, 5, and 7 d.p.i. by flow cytometry using defined lineage 
specific cell surface markers and gated as described in Methods and Supplemental Figure 3A-B (36). In WT 
mice, we observed a significant increase in the number of CD11bhiMHCIIlowLy6Chi classical monocytes after 
WSN infection which was blunted in SPCcre/HOIL-1Lfl/fl mice at all time points (Figure 3D). Similarly, recruitment 
of CD11bhiMHCIIhiCD24lowCD64hi monocyte-derived inflammatory macrophages was decreased by 45% in 
SPCcre/HOIL-1Lfl/fl mice as compared to WT mice at 7 d.p.i. (Figure 3E). While NK1.1+CD11bint NK cells were 
increased by 2-fold in the airspace of WT mice, NK cell numbers were significantly reduced in the lungs of 
SPCcre/HOIL-1Lfl/fl mice at the same time points (Figure 3F). Additionally, numbers of tissue resident 
SiglecFhiCD11chi alveolar macrophages and Ly6G+CD11bhiCD24hi neutrophils during IAV infection were similar 
in WT and SPCcre/HOIL-1Lfl/fl mice (Supplemental Figure 2G-H).  While the innate response is important to limit 
viral spread, clearance of IAV from an infected host is dependent on the adaptive response (37, 38). Analysis 
of lung lymphoid populations by flow cytometry (Supplemental Figure 3B) after IAV infection showed a 
significant increase in the number of CD44+CD62L-CD8+ effector T cells and of CD4+CD25+Foxp3+ Treg cells in 
infected SPCcre/HOIL-1Lfl/fl mice compared to WT mice (Figure 3G-H) In contrast, no differences were detected 
in the number of CD44+CD62L-CD4+ T cells between WT and SPCcre/HOIL-1Lfl/fl mice post infection 
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(Supplemental Figure 2I). Taken together these data suggest that LUBAC-dependent signaling at the epithelial 
level impacts multiple facets of the host immune response during IAV infection.  
To determine the impact of the decrease in viral titers (Figure 2D) on the protection from lung injury and 
decreased inflammation in IAV-infected SPCcre/HOIL-1Lfl/fl  mice, we administered a higher dose of WSN 
(WSNHigher) which resulted in viral titers at peak viremia comparable to those in WT mice infected with the 
standard lethal dose of WSN (WSNStdL) used in our in vivo model (Supplemental Figure 4A). SPCcre/HOIL-1Lfl/fl 
mice which received WSNHigher continued to display significantly reduced alveolar permeability, cellular 
infiltration, and IL-6 levels in BALF as compared to WT mice which received WSNStdL (Supplemental Figure 4B-
D). We observed no significant differences in BALF IFN-β levels between WSNStdL treated WT mice and 
WSNHigher treated SPCcre/HOIL-1Lfl/fl mice (Supplemental Figure 4E). These data suggests that decreased viral 
load does not drive the ameliorated lung injury in SPCcre/HOIL-1Lfl/fl mice. 
IAV infection increases HOIL-1L in alveolar epithelial cells 
Analysis of the effect of IAV infection on the expression of LUBAC components revealed a significant 
upregulation of HOIL-1L at both the mRNA and protein levels by 3 d.p.i. through 7 d.p.i. (Figure 4A-B) in AT2 
cells isolated from WT mice infected with WSN. No differences in HOIP or SHARPIN expression were detected 
(Supplemental Figure 5A-D). Similarly, when A549 cells were infected with 1 MOI WSN for 0, 4, 8, and 16 
hours, we measured a 5-fold increase in HOIL-1L mRNA and a 2-fold increase in HOIL-1L protein abundance 
by 16 hours post infection (h.p.i.) (Supplemental Figure 5E-F), again, with no changes in expression of the 
other LUBAC components (Supplemental Figure 5G-J).  
In addition to its role in stabilizing LUBAC to promote maximal activity of the complex (21, 27), it has been 
described that HOIL-1L has several LUBAC-independent functions, such as acting as an E3 ubiquitin ligase to 
target proteins such as PKCζ for degradation as seen in adaptation to hypoxia and cancer (23, 31, 39). Non-
denaturing native gel electrophoresis of lysates from WT AT2 cells or A549 cells exposed to WSN in vitro 
revealed that HOIL-1L runs consistent with the migration of  HOIP, to suggest association with LUBAC (25) 
(Figure 4C, Supplemental Figure 5K). These results suggest that during IAV infection newly synthesized HOIL-
1L is incorporated into LUBAC.  
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IAV infection upregulates HOIL-1L via autocrine and paracrine type I interferon signaling  
It has been described that virus infected epithelial cells signal to adjacent non-infected cells through the 
release of mediators, such as lipids, cytokines, and interferons (12, 40, 41). We sought to investigate whether 
the increase in HOIL-1L expression was a direct consequence of viral infection, a response to secreted 
autocrine and paracrine mediators, or both. At 0 and 3 d.p.i., single cell whole lung suspensions of WT AT2 
cells, defined as CD45- CD31- EpCam+, were FACS sorted based on the presence of the viral surface protein 
HA to separate infected (HA+) from non-infected (HA-) AT2 cell populations (Supplemental Figure 3C). 
Infection status of each population was confirmed by qRT-PCR, expression of IAV nucleoprotein (NP) (a viral 
genome associated protein necessary for replication in target cells) (Supplemental Figure 5L) (42). Analysis of 
mRNA from HA- and HA+ populations showed that infection with IAV was not required for HOIL-1L 
upregulation, as HOIL-1L mRNA was equally upregulated in both HA- and HA+ populations (Figure 4D). These 
results were recapitulated in vitro, where UV-irradiated conditioned media from untreated (CM-) or IAV infected 
(CM+) A549 cells was added to naïve cells. In response to CM+, a 2-fold induction of HOIL-1L was detected as 
early as 12 h.p.i., which was inhibited by heat denaturation of protein mediators within CM+ (Figure 4E). Taken 
together these results suggest that a protein mediator released from IAV-infected epithelial cells is sufficient to 
upregulate HOIL-1L in an autocrine or paracrine manner.  
We next sought to identify the cytokine(s) necessary for the observed autocrine/paracrine regulation of HOIL-
1L. It has been reported that IFN-α and IFN- can regulate the expression of LUBAC components in SHARPIN 
deficient mice (43). In our model, increased type I interferon (IFN-α, IFN-β) production in vivo paralleled HOIL-
1L upregulation (Fig 3B-C). Thus, we tested whether IFN-α was sufficient to increase HOIL-1L expression by 
treating A549 cells with recombinant human IFN-α, and found a significant increased HOIL-1L expression in 
A549 cell lysates (Figure 4F). Additionally, AT2 cells isolated from type 1 interferon receptor (IFNAR1) deficient 
mice (IFNAR1-/-) exposed to CM+ failed to upregulate HOIL-1L as compared to WT AT2 cells (Figure 4G). We 
obtained similar results with in vitro siRNA silencing of IFNAR1 compared to siControl transfected A549 cells 
treated with CM+ (Supplemental Figure 5M). To investigate whether direct viral infection was sufficient to 
induce HOIL-1L expression independent of IFNAR1 signaling, AT2 cells from IFNAR1-/- mice were infected 
with WSN. IFNAR1 deficiency inhibited HOIL-1L upregulation as compared to WSN infected WT AT2 cells, 
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despite active virus replication as measured by expression of the IAV non-structural protein 1 (NS1) 
(Supplemental Figure 5N). In vitro silencing of IFNAR1 yielded similar results, with inhibition of HOIL-1L 
upregulation as compared to siControl A549 cells treated with WSN (Supplemental Figure 3N). Conversely, 
upon CM+ (Supplemental Figure 5O) or WSN treatment (Fig, 5I), AT2 cells isolated from mice lacking the 
receptor for CCL-2/MCP1 (CCR2) upregulated HOIL-1L expression comparable with WT AT2 cells. These 
results suggest that signaling downstream of IFNAR1 is necessary to induce HOIL-1L expression in both 
human and mouse AEC.   
We sought to identify the transcription factor(s) regulating HOIL-1L downstream of IFNAR1. Interferon 
regulatory factors (IRF1-9) bind to variations of the interferon stimulated response element consensus 
sequence (44, 45) found within the HOIL-1L promoter (43). In silico analysis (46) of the human and mouse 
HOIL-1L promoters identified a shared putative binding site for IRF1. To validate a direct role of IRF1 in HOIL-
1L regulation we performed a ChIP assay, revealing a 5-fold increase in the direct binding of IRF1 to the HOIL-
1L promoter during WSN infection of A549 cells (Figure 4J). Additionally, in vitro silencing of IRF1 inhibited 
HOIL-1L upregulation in response to CM+ (Figure 4K). Collectively, the data suggest that IRF1 binds to HOIL-
1L promoter and regulates HOIL-1L induction in response to influenza-induced type I interferon signaling.  
Deletion of epithelial HOIP during IAV infection worsens lung injury and decreases survival 
To further assess the role of LUBAC in regulating the epithelial driven immune response to IAV, we generated 
a transgenic mouse with HOIP excised specifically from the lung epithelium (SPCcre/HOIPfl/fl) as described in 
Methods. Loss of HOIP protein levels, as well as the presence of HOIL-1L and SHARPIN was confirmed by 
immunoblot of WT and SPCcre/HOIPfl/fl AT2 cell lysates (Supplemental Figure 6A). Administration of low dose 
WSN to SPCcre/HOIPfl/fl mice significantly decreased survival compared to WT mice with a mean survival of 
11.5 and 13 d.p.i. respectively (Figure 5A). Additionally, careful examination of multiple parameters in H&E 
stained lung sections showed enhanced severity of lung injury in SPCcre/HOIPfl/fl mice as compared to WT at 7 
d.p.i. (Supplemental Figure 6B-C). The lethal dose of WSN resulted in 100% mortality in both WT and 
SPCcre/HOIPfl/fl mice by day 10 d.p.i., however, at earlier time points we observed differences in markers of 
lung injury, i.e. increased BALF protein (Figure 5B), and cell count (Figure 5C). Analysis of whole lung by 
plaque assay revealed an increase in viral load in SPCcre/HOIPfl/fl mice as compared to WT mice at peak 
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viremia 5 d.p.i. with no significant differences in viral clearance by 7 d.p.i. (Figure 5D). Consistent with our 
observations that loss of alveolar epithelial HOIP expression is detrimental in the response to IAV infection, 
data mined from a previously reported genome wide association study data set of 232 African American 
patients with ARDS and 162 at-risk control subjects (47) revealed a SNP in HOIP gene (rnf31) which coincides 
with worsened ARDS prognosis (Supplemental Figure 7). The identified SNP results in an amino acid change 
from valine to isoleucine (V1061I) between the RING2 and LDD domains of HOIP that make up the “catalytic 
core” (22, 27). Together these results support our findings in SPCcre/HOIL-1Lfl/fl mice that a degree of LUBAC 
activity is protective during inflammatory lung injury, as inhibition of LUBAC in SPCcre/HOIPfl/fl mice results in 
greater morbidity and mortality.  
AT2 cells isolated from SPCcre/HOIPfl/fl mice at 0 and 4 d.p.i. have a markedly impaired NF-κB response as 
shown by significantly decreased mRNA encoding Mcp1, Il6, and Ifnb compared to AT2 cells isolated from WT 
mice (Figure 6A-C). However, analysis of BALF revealed similar levels of IL-6 and MCP-1 between WT and 
SPCcre/HOIPfl/fl mice over the course of infection (Figure 6D-E) while IFN-β levels were dampened in 
SPCcre/HOIPfl/fl mice compared to WT mice at 5 d.p.i. (Figure 6F). Analysis of lung myeloid and lymphoid 
populations by flow cytometry at 0, 5, and 7 d.p.i. revealed similar recruitment of immune cell populations, in 
WT and SPCcre/HOIPfl/fl mice (Figure 6G-H, Supplemental Figure 6D-F). We detected similar numbers of 
SiglecFhiCD11chi alveolar macrophages (Supplemental Figure 6D), CD11bhiMHCIIhiCD24lowCD64hi monocyte-
derived inflammatory macrophages (Supplemental Figure 6E), and CD11bhiMHCIIlowLy6Chi classical monocytes 
(Supplemental Figure 6F) in WT and SPCcre/HOIPfl/fl mice. In contrast, we observed a significant reduction in 
neutrophil recruitment in SPCcre/HOIPfl/fl mice as compared to WT mice at 5 d.p.i. (Figure 6G) as well as a 2-
fold increase in the recruitment of NK1.1+CD11bint NK cells in SPCcre/HOIPfl/fl mice as compared to WT mice at 
7 d.p.i. (Figure 6H). Within the lymphoid lineage we detected a significant reduction in the number of 
CD44+CD62L-CD8+ T cells at 7.d.p.i. (Figure 6I) with no appreciable differences in the total number of either 
CD4+CD25+Foxp3+ Treg cells or CD44+CD62L-CD4+ T cells in SPC
cre/HOIPfl/fl mice compared to WT mice 
(Supplemental Figure 6G-H). Together these results suggest that a certain amount of LUBAC activity at level 
of the lung epithelium is necessary to coordinate the proper host response to IAV infection and confer 
protection from lung injury. 
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Restoration of NF-κB signaling in SPCcre/HOIPfl/fl mice reduces lung injury and improves survival during 
IAV infection. 
LUBAC is necessary for robust NF-κB activation, as linear ubiquitin chains on NEMO provide a stable docking 
site for additional IKK complexes, facilitating efficient activation of IKKα and IKKβ, and phosphorylation and 
degradation of IκBα (21, 28, 29). To confirm that loss of LUBAC-dependent NF-κB signaling in AT2 cells was 
driving mortality in IAV infected SPCcre/HOIPfl/fl mice, we utilized an adenovirus coding for the constitutively 
active form of IKKβ (AdIKKβ-CA) (48), the primary kinase responsible for phosphorylation of IκBα (49). 
SPCcre/HOIPfl/fl mice were instilled a non-coding adenovirus (AdNull) or AdIKKβ-CA, 14 days before infection 
with WSN (Supplemental Figure 8A). Expression of IKKβ was confirmed by immunoblot of isolated AT2 cell 
lysates (Figure 7B). While no difference in the content of IL-6 or IFN-β levels in BALF was observed between 
naïve and AdNull treated SPCcre/HOIPfl/fl mice was detected, IKKβ-CA was sufficient to induce their production 
(Supplemental Figure 8B-C). Taken together, these results suggest that overexpression of IKKβ-CA in 
SPCcre/HOIPfl/fl mice is sufficient to restore epithelial driven NF-κB signaling downstream of LUBAC.  
We next sought to determine if restoration of NF-κB signaling downstream of LUBAC in SPCcre/HOIPfl/fl mice 
would impact survival during IAV infection. Low dose WSN infection resulted in 100% mortality by 15 d.p.i. in 
SPCcre/HOIPfl/fl mice which received AdNull pre-treatment with AdIKKβ-CA resulted in significant protection 
(Figure 7A). Consistent with improved survival, we observed significant reductions in protein levels, infiltrating 
cell counts, and IL-6 in the BALF of SPCcre/HOIPfl/fl mice administered AdIKKβ-CA as compared to AdNull 
treatment prior to WSN infection (Figure 7C-E). Experiments were performed 7 days post WSN infection, a 
time at which both AdNull and AdIKKβ-CA treated SPCcre/HOIPfl/fl mice had lost a significant percentage of 
body weight (data not shown), but before any mortality events occurred (Figure 7A). Collectively, the data 
suggest that LUBAC-mediated NF-κB activation in lung epithelial cells is necessary for orchestration of a 
sufficient host response during IAV infection.  
Discussion 
IAV infection can cause severe pneumonia, respiratory failure and death (2, 4). A heterogeneous response to 
IAV with the same virulence exists within the population, suggesting that host factors play a crucial role 
regulating the inflammatory response and determining the severity of lung injury (2-4). While current anti-
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influenza strategies are limited to yearly vaccination or administration of antiviral drugs, it is clear that inclusion 
of strategies that target the host pathways will be beneficial (7, 50). Here we report that the level of LUBAC 
activity in pulmonary epithelial cells is a critical determinant of the NF-κB inflammatory response to IAV 
infection. Tight regulation of NF-κB is critical for the maintenance of immune homeostasis as its uncontrolled 
activation may result in “cytokine storm” with severe pathological consequences (13-17). During IAV infection, 
expression of the LUBAC component HOIL-1L is upregulated in alveolar epithelial cells by a mechanism that 
involves direct binding of IRF1 to the HOIL-1L promoter in response to type I interferons (Figure 8). This 
upregulation of HOIL-1L during IAV infection appears to be maladaptive, as attenuation of LUBAC activity by 
silencing of full length HOIL-1L in the lung epithelium is protective. In contrast, we show that complete loss of 
LUBAC activity, via deletion of HOIP in lung epithelial cells, leads to impaired epithelial driven immune 
response and increased mortality. In support of these observations, a SNP predicted to result in an amino acid 
change in the “catalytic core” of HOIP was associated with a worse prognosis in a cohort of African American 
patients with ARDS compared with controls. These findings highlight the fine line between an excessive and an 
inadequate immune response and suggest that therapeutic modulation of LUBAC activity may be crucial, as it 
functions as a rheostat regulating the amplitude of the host response to IAV infection.  
While several studies have focused on LUBAC signaling downstream of TNFRSF and the IL-1 receptor, 
changes in the expression of LUBAC components in these signaling pathways have not been reported (20-26, 
34, 35, 51). In contrast, we observed that during IAV infection, HOIL-1L expression is increased and 
associates with the other LUBAC components. We found that the binding of IRF1 directly to the HOIL-1L 
promoter downstream of IFNAR1 is necessary for HOIL-1L upregulation during IAV infection in both human 
and mouse AEC. While we found type I interferon signaling to be necessary, we cannot discount the possible 
combinatorial role of additional factors, as IRF1 has also been shown to be upregulated in response to IFN- 
and TNF-α stimulation (43, 52, 53). We detected very low levels of TNF-α in BALF in response to IAV infection 
to suggest a minor, if any, role for TNF-α signaling in in vivo HOIL-1L upregulation. IFN- plays an important 
role in the antiviral response and has a robust effect on IRF1 induction (43, 53), and while we do not observe 
an increase IFN- until 5 d.p.i., it may contribute to maintaining elevated levels of HOIL-1L during IAV infection. 
The molecular mechanism responsible for the increased levels of HOIL-1L during IAV infection may be of great 
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interest as it may contribute to increased LUBAC stability and the exaggerated production of cytokines during 
IAV infection.  
Expression of type I IFN early during infection restricts viral spread, both in the infected cell where interferon 
stimulated gene products directly target hijacked viral pathways, and in uninfected cells by priming an anti-viral 
state (17, 54). Due to the range of pathogenicity among IAV strains, divergent reports exist for the role of type I 
IFN signaling in limiting mortality during IAV infection (11, 55). However, a direct correlation between IAV-
induced high IFN-α/β levels and high morbidity and mortality has been reported (11, 54, 56, 57). As the 
infection persists, an exuberant and sustained interferon response can have deleterious effects by enhancing 
TRAIL mediated cell death (11) or facilitating secondary bacterial infections (57). Thus, we propose that the 
interferon-mediated regulation of HOIL-1L as host maladaptation to IAV infection, as we observe significant 
protection in SPCcre/HOIL-1Lfl/fl mice. While HOIL-1L does not directly contribute to linear ubiquitin chain 
formation (23, 27) its binding within LUBAC masks an ubiquitination site on HOIP to prevent its proteasomal 
degradation and releases HOIP’s auto-inhibitory fold to maximize LUBAC activity (23, 26, 27, 32). Thus, 
increased abundance of HOIL-1L may contribute to the enhanced stability and activity of LUBAC. As the 
stoichiometry of LUBAC has not been elucidated (23, 26, 27), increased LUBAC-associated HOIL-1L may 
represent an increase in the ratio of HOIL-1L within the complex or an increase in the abundance of LUBAC 
complexes, either of which contribute to enhanced NEMO linear ubiquitination and robust downstream NF-κB 
activation (Figure 8).  
Loss of LUBAC activity has been shown to have cell type specific effects (23, 58-60). For example, patients 
with LUBAC deficiency present with both auto inflammation and immunodeficiency. In mice, global HOIP and 
HOIL-1L null mice are embryonically lethal, while global SHARPIN deficiency results in viability with multiorgan 
inflammation. In contrast, HOIL-1L-/- mice, which express a low level of truncated N-terminal HOIL-1L, which 
retains the UBL and LTM domains for heterotrimeric LUBAC formation (N-HOIL-1L) (33), are viable with no 
overt phenotype. To circumvent confounding cell type specific phenotypes in vivo, we utilized a pulmonary 
epithelial cell specific transgenic mouse model (SPCcre). SPCcre/HOIL-1Lfl/fl mice lack full length HOIL-1L and 
express a low level N-HOIL-1L, and thus are capable of a certain level of LUBAC-dependent signaling. While it 
has been reported that influenza infection of mice with chronic proliferative dermatitis due to global SHARPIN 
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deficiency results in decreased survival compared to WT mice (61), here we have shown that IAV infection of 
phenotypically normal SPCCre/HOIL-1Lfl/fl mice resulted in increased survival compared to WT mice. While the 
mice utilized in this study have low expression of the truncated variant of HOIL-1L and may retain some 
LUBAC activity, SPCcre/HOIL-1Lfl/fl mice have significantly reduced cytokine and interferon levels in response to 
IAV infection. This is consistent with our in vitro data were silencing of full length HOIL-1L reduced the linear 
ubiquitination of NEMO, activation of NF-κB and IRF3, and IL-6 and IFN-β secretion. Additionally, studies in 
which mouse embryonic fibroblasts derived from HOIL-1L-/- mice, which do not express full length HOIL-1L, but 
instead express the truncated variant (21) have reduced levels of 600 kDa LUBAC (32) as well as impaired 
NF-κB signaling (21). These findings suggest that deletion of full length HOIL-1L and low expression of the 
truncated N-terminal fragment, is sufficient to destabilize LUBAC, and reduce LUBAC-dependent inflammatory 
signaling. We find that fine-tuning of LUBAC activity, though deletion of lung epithelial full length HOIL-1L is 
protective during IAV infection, reducing lung injury, viral titers and promoting survival.  
The effects of lung epithelial HOIL-1L deletion on the innate and adaptive immune responses to IAV infection 
suggest that multiple mechanisms may be responsible for the lower viral titers, reduced injury and improved 
survival in SPCcre/HOIL-1Lfl/fl mice compared with WT mice. During IAV infection respiratory epithelial cells 
produce large amounts of MCP-1, resulting in the recruitment of classical monocytes and inflammatory 
monocyte-derived macrophages which produce large amounts of cytokines and are the predominant cause of 
immune pathology during influenza infection (14, 56). NK cells recruited to the lung also contribute to tissue 
damage as they target infected AEC for destruction, sacrificing barrier integrity in an effort to limit viral spread 
(62, 63). As such, reductions in inflammatory cytokines, classical monocytes inflammatory monocyte-derived 
macrophages, and NK cells seen in IAV-infected SPCcre/HOIL-1Lfl/fl mice likely play a significant role in the 
protection from lung injury and increased survival during IAV infection. In addition, CD8+ T cells were increased 
in SPCcre/HOIL-1Lfl/fl mice as compared to WT mice. The specific targeting of infected AEC by CD8+ T cells, is 
the primary mode of viral clearance in the IAV-infected lung (64). While we show that the improved survival 
was not exclusively attributable to lower viral loads, as SPCcre/HOIL-1Lfl/fl mice remain protected after infection 
with a higher titer of virus, increased antiviral CD8+ T cells in SPCcre/HOIL-1Lfl/fl mice may contribute to the 
measured decrease in peak viral titers and contribute to potential long term survival. In support of this, it has 
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been reported that IAV infection of T cell deficient mice resulted in a lower survival rate by 21 d.p.i, persistent 
lung injury and higher viral titers compared to WT mice (64, 65). Moreover, there was a significant increase in 
the number of Treg cells in SPCcre/HOIL-1Lfl/fl mice as compared to WT mice. Treg cells contribute to both 
quelling the inflammatory response to limit tissue damage as well as the promotion of tissue repair (66). 
Together with the concurrent increased levels of the anti-inflammatory cytokine IL-10 in SPCcre/HOIL-1Lfl/fl mice 
as compared to WT mice, our results suggest reduced inflammation confers protection during IAV infection. 
This supported by clinical findings in patients with worse outcomes of the pandemic 2009 H1N1 IAV who had 
elevated levels of circulating IL-6 despite viral clearance (15). These findings highlight the ability of LUBAC-
dependent lung epithelial signaling to coordinate multiple components of the immune responses to IAV 
infection.  
A balance between an excessive and inadequate immune response to infection is necessary for optimal 
recovery from IAV infection. In contrast to SPCcre/HOIL-1Lfl/fl mice, genetic deletion of HOIP in lung epithelial 
cells resulted in worse lung injury and decreased survival in response to IAV infection. These findings are in 
agreement with worse ARDS prognosis associated with a SNP within the “catalytic core” of HOIP, which may 
affect its activity or protein-protein interactions necessary for NF-κB activation. AT2 cells from SPCcre/HOIPfl/fl 
mice infected with a lethal dose of WSN had significantly reduced mRNA expression of inflammatory cytokines, 
while total BALF cytokine concentrations were comparable. As such, we believe another cell type is driving the 
inflammatory response to IAV infection in SPCcre/HOIPfl/fl mice. It has been shown by several groups, in several 
models, (TNF-α, TRAIL, cisplantin) that loss of HOIP from a cell, sensitizes it to induction of cell death (51, 61, 
67, 68). This enhanced cell death in the absence of HOIP may account for the alternative activation of 
inflammation, as dying cells can release damage-associated molecular patterns that can induce inflammation 
(69). LUBAC inhibits several proteins involved in the induction of both apoptosis and necroptosis, as well as 
stabilization of anti-apoptotic proteins, and expression of NF-kB dependent pro-survival genes. As such, loss 
of HOIP from the respiratory epithelium may have pleiotropic effects. Influenza virus can induce intrinsic cell 
death pathways to cause epithelial cell death, which would release damps that activate resident immune cells. 




Use of a constitutively active mutant of IKKβ to bypass linear ubiquitin-dependent signaling and restore the NF-
κB pathway in HOIP-deficient cells improved survival and reduced lung injury in SPCcre/HOIPfl/fl mice during IAV 
infection, further supporting the crucial role of LUBAC-dependent signaling in regulating the host response to 
IAV infection. SPCcre/HOIPfl/fl mice reconstituted with constitutively active IKKβ have restored NF-κB signaling, 
including the production of IL-6 and IFN-β (Supplemental Figure 8B-C). As such, upon IAV infection, IKKβ-CA 
expressing SPCcre/HOIPfl/fl alveolar epithelial cells are able to initiate host response by activating NF-κB 
downstream of LUBAC. In addition to the restored epithelial cells driven production of cytokines and 
interferons, rescue of the NF-κB pathway may induce the upregulation of pro-survival genes to reduce IAV-
induced cell death pathways and contribute to the improved survival in AdIKKβ-CA treated SPCcre/HOIPfl/fl 
mice.  Collectively, restoration of the NF-κB pathway in SPCcre/HOIPfl/fl respiratory epithelial cells shifts 
origination of the inflammatory to IAV response back to the epithelium. Taken together, our data underscore 
the critical importance of LUBAC mediated NF-κB signaling in the alveolar epithelium orchestration of the host 
response to viral infections.  
In conclusion, we show that during IAV infection, the amplitude of the inflammatory response is modulated by 
alveolar epithelial LUBAC activity which serves as a molecular rheostat and regulates the host response. While 
several chemical inhibitors as well as peptides that bind HOIP have been used to inhibit LUBAC activity in cell 
culture (70-73) and in vitro assays (74, 75) and support the targetablility of LUBAC, we have demonstrated that 
complete loss of HOIP is detrimental during IAV infection, however, some destabilization of LUBAC through 
loss of HOIL-1L is beneficial. Thus, novel compounds which target LUBAC stability to modulate LUBAC activity 
may be therapeutically beneficial for the treatment of hyperinflammatory response during IAV infection, were a 
modest degree of host response is necessary.  
Methods 
Mouse strains 
Mice were bred in a barrier facility at Northwestern University. SPCcre/Rbck1(HOIL-1L)fl/fl mice on a C57BL/6  
background were generated as previously described (31). Rnf31(HOIP)fl/fl mice were generated on a C57BL/6 
background by Ozgene Pty Ltd. (Perth, Australia). Briefly, a conditional allele of HOIP was generated by 
flanking exon 6 with loxP sites, generating a translational frameshift and rendering downstream exons non-
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functional.  A neomycin cassette flanked by FRT sites was used for selection in embryonic stem cells. 
Subsequent breeding of wt/flox to wt/flp mice removed the neomycin cassette. Heterozygous crossing bred out 
flp and generated homozygous HOIPfl/fl mice. HOIPfl/fl mice were then bred to SPCcre mice for the specific 
deletion of HOIP from alveolar epithelial cells. The SPCcre/HOIPfl/fl colony was maintained by crossing HOIPfl/fl 
to SPCcre/HOIPfl/fl. Deletion was confirmed through genotyping (Transnetyx) and by immunoblotblot of AT2 
lysates with specific antibodies. B6.129S2-Ifnar1tm1Agt/Mmjax (IFNAR1-/-) and B6.129S4-Ccr2tm1Ifc/J (CCR2-/-) 
mice were purchased from Jackson Laboratory and have been previously described (76) (85(77). Mice were 
provided with food and water ad libitum and maintained on a 14-h light/10-h dark cycle.  
Histology  
Lungs were fixed and processed as previously described (31). Brightfield images were obtained using 
TissueFAXS software (TissueGnostics). Quantification of severity of lung injury from H&E images was based 
peribronchial infiltration, bronchial exudate, and alveolar infiltration.  
Reagents 
The following pooled siRNA were purchased from Santa Cruz Biotechnology (Scbt) and used at the indicated 
concentrations: siRBCK1(HOIL-1L) (sc-61446, 60 pmol), siIRF1 (sc-35706, 70 pmol), siSHARPIN (sc-77833, 
120 pmol), siIFNAR1 (sc-35637, 70 pmol), and a scrambled non-targeting control (sc-37007) at corresponding 
concentrations. Additional reagents include siHOIP(RNF31) (Qiagen #141713365, 120 pmol), Lipofectamine 
RNAiMAX (Fisher Scientific, #13778075), and recombinant human IFN-α (BioLegend, #592704, 100 U/mL).  
Cell culture  
A549 (ATCC), MDCK (ATCC) and AT2 cells isolated and cultured as previously described (31). Cell lines were 
routinely tested for mycoplasma contamination using the MycoAlert kit (Lonza).  
Immunoprecipitation and Immunoblot analysis 
Immunoprecipitation was performed as previously described (78). Briefly, protein concentrations were 
incubated with A/G agarose beads (Scbt, sc-2003) and an anti-NEMO antibody (1ug, Scbt, sc-8330) rotating 
overnight. Beads were washed 3 times in 1% w/v Triton X-100, 20 mM Tris–HCl (pH 7.5), 150 mM NaCl and 
eluted proteins analyzed by immunoblot. Immunoblotting was performed by resolving protein lysates on SDS-
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PAGE gels (7.5-10 %), followed by transfer to nitrocellulose membranes (Bio-Rad) and further incubation of 
membranes with indicated antibodies overnight (see Supplemental Table 1). HRP-tagged secondary 
antibodies (Bio-Rad, 1721011 and 1721019) were used in combination with Super-Signal ECL kit (Thermo 
Fisher) to develop immunoblots using a LI-COR Odyssey Imager and companion software Image Studio 
version 5.2. Immunoblots were quantified using densitometry (ImageJ 1.46r; National Institutes of Health, 
Bethesda, MD) (19).  
Influenza A virus infection 
Influenza A virus strain A/WSN/33(H1N1) was used for in vitro and in vivo experiments. A549 cells were 
seeded in 35 mm dishes at a density of 2x105 cells per well and infected at 1 MOI for 16 hours in DMEM. 
Primary mouse AT2 cells were seeded in a 12 well plate format at a density of 3x106 cells per well and infected 
at 1 MOI for 16 hours in DMEM. Conditioned media was removed from infected cells and exposed to UV light 
for 15 minutes on ice for virus inactivation before addition to naïve cells (79). As a control, UV-treated 
supernatant was boiled (99º C) for 10 minutes to denature proteins.  
For in vivo infections, anesthetized mice were i.t. inoculated with WSN diluted in 50 L sterile PBS as 
described (80). A dose of 500 plaque forming units (PFU) per mouse was used for lethal infections and 100 
PFU for the sublethal dose. For survival studies, upon developing a moribund condition (slowed respiration, 
hunched posture, lack of curiosity, little or no response to stimuli and not moving when touched) mice were 
euthanized and recorded as IAV-induced mortality. BALF was collected using 1 mL of PBS instilled into the 
lungs and aspirated three times (81, 82). 
Determination of viral titer  
Whole lung homogenates were serially diluted in DMEM containing 1% BSA were added to MDCK cells 
followed by a standard plaque assay protocol (83). Plaques were counted at each dilution to calculate viral 
titer.  
Flow cytometry and cell sorting 
Multicolor flow cytometry and cell sorting were performed with an LSR Fortessa or BD FACSAria cell sorter 
using DIVA software (BD Biosciences). Analysis was performed off line using FlowJo software (v10.1).  
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Myeloid and lymphocyte populations from whole lung were isolated and defined as previously described (36, 
84, 85). Briefly, perfused lungs were inflated with digestion buffer (1 mg/mL of Collagenase D and 0.1 mg/mL 
DNase I, both from Roche) and coarsely minced before processing in C-tubes (Miltenyi Biotec) with a 
GentleMACS dissociator (Miltenyi Biotec), according to the manufacturer’s instructions. Homogenate was 
passed through 40-μm nylon mesh to obtain a single-cell suspension and subjected to red blood cell lysis (BD 
Pharm Lyse, BD Biosciences). Live cells were counted using a Countess cell counter (Invitrogen) by trypan 
blue exclusion.  
Cells were stained with antibodies listed in Supplemental Table 2-3 and gated as described elsewhere (19, 36) 
and outlined in Supplemental Figure 3A-B. For lymphoid analysis, cells were first permeabilized with the 
FOXP3 staining kit (eBioscience, 005523) according to manufacturer’s instructions.  
AT2 cells were isolated and sorted as previously described (12).  Briefly, perfused lungs treated with dispase 
(Corning # 47743-724) and DNase (50mg/mL, Sigma-Aldrich # D4513-1VL) were subjected to manual 
dissection. Single cell suspensions were enriched for epithelial cells using anti-EpCAM magnetic microbeads 
(Milteny Biotec # 130-105-958). Cells were stained with antibodies listed in Supplemental Table 4 and gated as 
outlined in Supplemental Figure 3C.  
Native PAGE analysis 
For analysis of native LUBAC formation, the Invitrogen Blue Native Gel system (Invitrogen, BN2007, BN2008) 
was utilized according to manufacturer’s instructions and as described elsewhere (86). Briefly, cells were lysed 
in provided sample buffer containing 1% Digitonin and resolved on 3-12% bis-tris gel (Invitrogen, BN1001). 
Proteins were transferred to a PVDF membrane and immnoblotted as described above.  
Cytokine determination 
ELISAs were carried out on cell culture supernatants or BALF according to manufacturer’s instructions using 
the following kits: IL-6(h) (Thermo Fisher, KHC0061C), IFN-β(h) (PBL Assay Science, 41410), IL-6(m) 
(Thermo Fisher, KMC0062), MCP-1(m) (Thermo Fisher EMMCP1), IFN-α(m) (PBL Assay Science, 42120), 
IFN-β(m) (PBL, 42400),  IFN-γ(m) (Thermo Fisher, BMS606), and IL-10(m) (Thermo Fisher, EM2IL10).  
Chromatin immunoprecipitation assay.  
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Chromatin immunoprecipitation was performed using the Simple ChIP Enzymatic Chromatin IP kit (Cell 
Signaling, 9003) according to manufacturer’s instructions. Briefly, cells were cross-linked with formaldehyde 
and lysed with provided buffers. Cell lysates were subjected to sonication and nuclease treatment before 
immunoprecipitation with provided control IgG (5 ug) or IRF1 (10 ug, Scbt, sc-497) using provided magnetic 
beads. Bead eluates were then subjected to proteinase digestion and qPCR amplification of the HOIL-1L 
promoter (Forward: 5’TTAGCTTCAGTGTTCCCCCT-3’, Reverse: 5’-CAGTGGGGAGACAATGAACAA-3’) 
using SybrGreen (BioRad, 1708880).  
Quantitative RT-PCR 
Cellular mRNA was collected and purified using RNeasy mini kit (Qiagen, 74104) before cDNA preparation 
with qScript cDNA synthesis kit (Quanta Bio, 95047). For qRT-PCR, IQ SybrGreen master mixes (Bio-Rad, 
1708880) were used according to manufacture’s instructions with the primers listed in Supplemental Table 5.  
Statistics 
Analyses of significance were performed using GraphPad Prism (v.7.02) software. A P value ≤0.05 was 
considered statistically significant.  A standard two-tailed unpaired Student’s t-test was used for two groups. 
One-way ANOVA, followed by analysis-specific post-tests, was carried out when more than two variables were 
compared. Data are presented means ±s.d. overlaid with individual data points representing replicates. 
Statistical analysis of survival curves was performed with a two-sided log-rank (Mantel–Cox) test.  
Study approval 
All in vivo experiments were performed in compliance with the institutional and US National Institutes of Health 
guidelines and were approved by the Northwestern University Animal Care and Use Committee. 
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Figure 1.  Linear Ubiquitin chains modulate the NF-κB response to IAV downstream of RIG-I signaling 
in vitro.  (A) Simplified signaling pathway (B-F) A549 cells infected with WSN (1 MOI, 16 h) after transfection 
with non-targeting siRNA (siControl) or siRNA against either HOIL-1L or HOIP. (B-E) Representative 
immunoblots of (B-C) RIG-I activation (n=4). (D) Linear ubiquitination of NEMO (n=3) (E) p-IkBα, total IkBα, p-
IRF3, total IRF3 (n=4). (F-G) Cytokines in the supernatant were determined by ELISA (F) IL-6 (n=4) (G) IFN-β 
(n=4).  Mean ± s.d. overlaid with individual data points representing replicates are depicted, *P < 0.05, **P < 






Figure 2.  Loss of HOIL-1L from the alveolar epithelium improves survival and reduces lung injury in 




mice infected with a low (n=18, dashed line) 
or lethal (n=30, solid line) dose of WSN. (B-C) BALF was collected at 0 (n=5), 3, 5 and 7 d.p.i. (n=18) with a 
lethal dose of WSN and analyzed for (B) total protein concentration and (C) cellular infiltration. (D) 




mice at 3, 5, and 7 d.p.i. (n=9). Mean ± s.d. overlaid 
with individual data points representing replicates are depicted, *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 











mice were infected with a lethal dose of WSN. (A-C). BALF at 0 (n=5), 3, 5 and 7 
d.p.i. (n=9) was analyzed by ELISA for (A) IL-6 (B) IFN-α (C) IFN- (D-H) Lung immune cell populations at 0 




































 cells. Mean ± s.d. overlaid with individual data points 
representing replicates are depicted, *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001 (one-way ANOVA, 




Figure 4.  HOIL-1L is upregulated during IAV infection though a type I interferon receptor signaling 
axis. (A-B) AT2 cells isolated from WT mice 0, 3, 5 and 7 d.p.i. (A) HOIL-1L mRNA (n=5) (B) Representative 
HOIL-1L immunoblot and its quantification (n=4). (C) Representative native PAGE immunoblot of HOIL-1L and 
HOIP expression in AT2 cells infected in vitro with WSN (n=3). (D) HOIL-1L mRNA expression in AT2 cells 
from WT mice 0 and 3 d.p.i. sorted based on expression of the viral protein HA (n=8). (E-I) Representative 
HOIL-1L immunoblot and quantification in (E) A549 cells treated for 0, 8, 12 and 16 hours with conditioned 
media (CM), * indicated boiled CM (n=4). (F) A549 cells treated with recombinant IFN-α (n=4). (G) AT2 cells 
isolated from WT and IFNAR1
-/- 
mice treated in vitro with CM (n=3) (H-I) AT2 isolated from WT and (H) 
IFNAR1
-/-
 mice treated in vitro with WSN (n=3) (I) CCR2
-/- 
mice treated in vitro with WSN (n=4) (J) qRT-PCR 
quantification of HOIL-1L promoter after ChIP of IRF1 in A549 cells (n=4) (K)  Representative HOIL-1L 
immunoblot and quantification in siControl or siIRF1 transfected A549 cells treated with CM (n=4) (L) Proposed 
type I IFN pathway leading to HOIL-1L upregulation. Mean ± s.d. overlaid with individual data points 
representing replicates depicted, *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001 (one-way ANOVA, 




5.  Loss of HOIP from the alveolar epithelium decreases survival and enhances lung injury in mice 




mice infected with a low (n=18, dashed line) or 
lethal (n=13, solid line) dose of WSN. (B-C) BALF was collected from at 0, 3, 5 and 7 d.p.i. (n=9) and analyzed 
for (B) total protein concentrations and (C) cellular infiltration. (D) Quantification of viral titers in WT and 
SPCcre/HOIP
fl/fl
 at 3, 5, and 7 d.p.i. (n=9). Mean ± s.d. overlaid with individual data points representing 
replicates are depicted *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001 (A, two-tailed log-rank Mantel-Cox 







Figure 6. Loss of HOIP from the alveolar epithelium inhibits alveolar epithelial driven inflammatory 




mice infected with a lethal dose of WSN (A-B) AT2 
cells at 0 and 4 d.p.i. (n=9) analyzed for (A) Il6 mRNA (B) Mcp1 mRNA (C) Ifnb mRNA. (D-F) BALF analyzed 
by ELISA at 0, 3, 5, 7 d.p.i. (n=9) for (D) IL-6 (E) MCP-1 (F) IFN-. (G-I) Lung immune cell populations at 0, 5 



















T cells. Mean ± s.d overlaid with Individual data 
points representing replicates are depicted, *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001. (one-way 








 mice improves survival in response to IAV 
infection (A) Survival curve of SPCcre/HOIP
fl/fl 
mice administered either AdNull (n=11, solid line) or AdIKK-β-
CA (n=10, dashed line) followed by low dose WSN. (B) Immunoblot of AT2 cell lysates showing 
overexpression of IKKβ (n=3) (C-E) BALF from SPCcre/HOIP
fl/fl 
mice administered either AdNull or AdIKK-β-CA 
collected at 0 (n=3), and 7 d.p.i. (n=7) of low dose of WSN and analyzed for (C) total protein concentration, (D) 
cellular infiltration and (E) IL-6. Mean ± s.d overlaid with Individual data points representing replicates are 
depicted, *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001. (A, two-tailed log-rank Mantel-Cox test; C-E, one-




Figure 8.  Cartoon representing HOIL-1L upregulation via IRF1 in AT2 cells Upon IAV infection, LUBAC-
dependent activation of NF-κB and IRF3 pathways occurs downstream of RIG-I. Subsequent release of pro-
inflammatory cytokines and type 1 interferons recruit immune cells to the airspace, contributing to the growing 
cytokine storm. In non-infected AT2 cells, IFN secreted either by epithelial cells or the recruited immune cells, 
binds to IFNAR1 triggering a signal cascade that upregulates HOIL-1L via IRF1. Newly synthesized HOIL-1L 
may either contribute to increased number of LUBAC complexes or a change in LUBAC stoichiometry to 
include a higher ratio of HOIL-1L within the complex. Both situations result in LUBAC increased stability and 
exaggerated production of cytokines which contributes to the morbidity and mortality observed in severe cases 
of influenza infection. 
